These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 20813663)
1. [PKD3 contributes to up-regulation of prostate-specific antigen in prostate cancer cells]. Deng F; Wang CX; Xu WF; Feng L; Ke ZY; Wang QJ; Zou ZP Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1779-82. PubMed ID: 20813663 [TBL] [Abstract][Full Text] [Related]
2. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
3. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms. Jia L; Kim J; Shen H; Clark PE; Tilley WD; Coetzee GA Mol Cancer Res; 2003 Mar; 1(5):385-92. PubMed ID: 12651911 [TBL] [Abstract][Full Text] [Related]
4. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430 [TBL] [Abstract][Full Text] [Related]
5. Synergistic activation of the androgen receptor by bombesin and low-dose androgen. Dai J; Shen R; Sumitomo M; Stahl R; Navarro D; Gershengorn MC; Nanus DM Clin Cancer Res; 2002 Jul; 8(7):2399-405. PubMed ID: 12114445 [TBL] [Abstract][Full Text] [Related]
6. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977 [TBL] [Abstract][Full Text] [Related]
7. [Protein kinase D3 is involved in negative regulation of MMP-7 in prostate cancer cells]. Zou ZP; Feng L; Xu WF; Ke ZY; Wang QJ; Deng F Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1767-70. PubMed ID: 20813660 [TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600 [TBL] [Abstract][Full Text] [Related]
9. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells. Ikezoe T; Chen SS; Yang Y; Heber D; Taguchi H; Koeffler HP Int J Oncol; 2003 Nov; 23(5):1461-70. PubMed ID: 14532991 [TBL] [Abstract][Full Text] [Related]
10. Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells. Alexander B; Fishman AI; Green D; Choudhury MS; Konno S Urol Oncol; 2013 Jan; 31(1):104-9. PubMed ID: 21795077 [TBL] [Abstract][Full Text] [Related]
11. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040 [TBL] [Abstract][Full Text] [Related]
12. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer. van der Poel HG Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107 [TBL] [Abstract][Full Text] [Related]
13. Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3'-diindolylmethane (ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells. Abdelbaqi K; Lack N; Guns ET; Kotha L; Safe S; Sanderson JT Prostate; 2011 Sep; 71(13):1401-12. PubMed ID: 21321979 [TBL] [Abstract][Full Text] [Related]
14. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells. Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155 [TBL] [Abstract][Full Text] [Related]
15. Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells. Fujii Y; Kawakami S; Okada Y; Kageyama Y; Kihara K Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E927-31. PubMed ID: 14761877 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related]
17. Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cells. Bruckheimer EM; Spurgers K; Weigel NL; Logothetis C; McDonnell TJ J Urol; 2003 Apr; 169(4):1553-7. PubMed ID: 12629413 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells. Thelen P; Wuttke W; Jarry H; Grzmil M; Ringert RH J Urol; 2004 May; 171(5):1934-8. PubMed ID: 15076315 [TBL] [Abstract][Full Text] [Related]
19. Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line. Wang LG; Ossowski L; Ferrari AC Cancer Res; 2001 Oct; 61(20):7544-51. PubMed ID: 11606392 [TBL] [Abstract][Full Text] [Related]
20. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines. Paliouras M; Diamandis EP Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]